Genomic alterations associated with resistance to EGFR monoclonal antibodies (mAb) in real-world patients with metastatic colorectal cancer (mCRC).

被引:0
|
作者
Klempner, Samuel J.
Quintanilha, Julia C. F. C. F.
Emmett, Matthew
Graf, Ryon
Schrock, Alexa Betzig
Tukachinsky, Hanna
Oxnard, Geoffrey R.
Myer, Parvathi
机构
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Fdn Med Inc, Boston, MA USA
[3] Dana Farber Canc Inst, Boston, MA USA
[4] Fdn Med Inc, Cambridge, MA USA
[5] Albert Einstein Canc Ctr, New York, NY USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
52
引用
收藏
页码:52 / 52
页数:1
相关论文
共 50 条
  • [31] Frequency and management of trifluridine/tipiracil (FTD/TPI) plus bevacizumab (BEV)-associated neutropenia in patients with refractory metastatic colorectal cancer (mCRC) in real-world practice
    Lago, N. Martinez
    Rendo, C. Reboredo
    Chucla, T. Calleja
    Salvador, M. Mateos
    Fernandez, F. Busto
    Gomez, J. de la Camara
    Reboredo-Lopez, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S100 - S101
  • [32] Regorafenib plus tislelizumab for patients with metastatic colorectal cancer: A real-world study
    Gao, Xiang
    Chen, Xiaoping
    Zhao, Yutian
    Mao, Yong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] Real-world safety and effectiveness of MVASI in metastatic colorectal cancer patients in Canada
    Cheung, Winson Y.
    Samimi, Setareh
    Ma, Kim
    Knight, Gregory John
    Kassam, Shaqil Nadirali
    Colwell, Bruce
    Beaudoin, Annie
    Vincent, Mark David
    Trinkaus, Mateya
    Filion, Alain
    Karachiwala, Hatim
    Asmis, Timothy
    Sideris, Lucas
    Nunez, Leyla
    Wani, Rajvi
    Morris, Carlye Cirone
    Ngan, Elaine
    Du, Yinhao
    Inam, Naila
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Real-world use of trifluridine/tipiracil for patients with metastatic colorectal cancer in Canada
    Samawi, H. H.
    Brezden-Masley, C.
    Afzal, A. R.
    Cheung, W. Y.
    Dolley, A.
    CURRENT ONCOLOGY, 2019, 26 (05) : 319 - +
  • [35] Real-world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer
    Xu, Ting
    Li, Jian
    Wang, Zhenghang
    Zhang, Xiaotian
    Zhou, Jun
    Lu, Zhihao
    Shen, Lin
    Wang, Xicheng
    CANCER MEDICINE, 2023, 12 (09): : 10473 - 10484
  • [36] Real-world (RW) study in patients (pts) with metastatic colorectal cancer (mCRC) with long-term responses to regorafenib in the USA.
    Kim, Richard D.
    Pan, Xiaoyun
    Ostojic, Helene
    Zhang, Yiqiao
    Lunacsek, Orsolya
    Pisa, Federica
    Peeters, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 48 - 48
  • [37] Real-world comparison of triplet-versus doublet-chemotherapy with bevacizumab in patients with newly diagnosed metastatic colorectal cancer (mCRC)
    Chapin, William Joseph
    Hwang, Wei-Ting
    Mamtani, Ronac
    O'Hara, Mark H.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] Molecular Characterization of Acquired Resistance To Anti-EGFR Monoclonal Antibodies in Colorectal Cancer Patients
    Bellosillo, Beatriz
    Dahnases, Alba
    Martinez, Alejandro
    Iglesias, Mar
    Gonzalez, Irio
    Salido, Marta
    Busto, Marcos
    Sanchez, Juan
    Vidal, Joana
    Clave, Sergi
    Moragon, Ester
    Pairet, Silvia
    Bellmunt, Joaquim
    Serrano, Sergio
    Rovira, Ana
    Albanell, Joan
    Montagut, Clara
    LABORATORY INVESTIGATION, 2015, 95 : 148A - 148A
  • [39] Prevalence of acquired (acq) genomic alterations (GAs) after progression on anti-EGFR mAb (EGFRi) based therapy in metastatic colorectal cancer (mCRC): A systematic review and meta-analysis
    Raghav, K.
    Sun, R.
    Willis, J.
    Morris, V.
    Eluri, M.
    Dasari, N. A.
    Yuan, Y.
    Kopetz, S.
    Parseghian, C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S702 - S703
  • [40] Molecular Characterization of Acquired Resistance To Anti-EGFR Monoclonal Antibodies in Colorectal Cancer Patients
    Bellosillo, Beatriz
    Dalmases, Alba
    Martinez, Alejandro
    Iglesias, Mar
    Gonzalez, Iria
    Salido, Marta
    Busto, Marcos
    Sanchez, Juan
    Vidal, Joana
    Clave, Sergi
    Moragon, Ester
    Pairet, Silvia
    Bellmunt, Joaquim
    Serrano, Sergio
    Rovira, Ana
    Albanell, Joan
    Montagut, Clara
    MODERN PATHOLOGY, 2015, 28 : 148A - 148A